Reported adverse events during and at the end of follow-up among diabetic peripheral neuropathy patients.
| Adverse events | Carbamazepine n=85 | Pregabalin n=86 n (%) | Venlafaxine n=86 |
|---|---|---|---|
| Agitation | 0 (0.0) | 0 (0.0) | 4 (4.7) |
| Dizziness | 10 (11.8) | 63 (73.2) | 36 (41.9) |
| Vomiting | 0 (0.0) | 0 (0.0) | 3 (3.5) |
| Impotency | 1 (1.2) | 1 (1.2) | 4 (4.7) |
| Somnolence | 3 (3.5) | 46 (53.3) | 20 (23.3) |
| Asthenia | 1 (1.2) | 5 (5.8) | 11 (12.7) |
| Headache | 0 (0.0) | 0 (0.0) | 18 (20.9) |
| Nausea | 1 (1.2) | 0 (0.0) | 30 (34.9) |
| Bulimia | 2 (2.4) | 0 (0.0) | 2 (2.4) |
| Dyspepsia | 1 (1.2) | 2 (2.3) | 2 (2.4) |
| Edema | 0 (0.0) | 2 (2.3) | 2 (2.3) |
| Weight changes | 1 (1.2) | 4 (4.6) | 2 (2.4) |